However, if you have renal impairment, hepatic disease, cardiovascular instability, or are using medications that interact with GLP-1 metabolism, you should discuss any timing changes with your healthcare provider before adjusting your schedule
It reduces key fibrotic markers, including -SMA and collagen, by blocking the TGF-/Smad2/3 signaling pathway
Injections were considered
doi: 10.3109/00365529709000195 121 PortnoyD
This is why it is critical to consult a provider before stopping, as they may need to adjust other medications like metformin or insulin to keep your levels safe
Most side effects peak during the first 90 days of treatment and then improve once the patient is on a stable, maintenance dose